Our Board

Board of Directors

Next Board of Directors meeting:   Wednesday,  December 19, 2018 at 10 a.m. at the PCSANM office

 

Steve Denning

Steve Denning

Chairman of the Board

Steve was first diagnosed in 2009 and treated with brachytherapy and cryotherapy the next year.  His PSA continues to stay low.  He joined the board of PCSANM in 2014 and wishes he had known about the organization at the time of his treatment.  Steve is now retired but worked most of his life as a video producer in advertising and manufacturing.  Steve has been a private business owner but his last 17 years working were at Intel.  He is happy to share the knowledge and experience he gained in his role on the board and as a volunteer.
Rod Geer

Rod Geer

Vice Chair

Rod joined the board in spring 2017, not quite a year after his prostatectomy at the University of New Mexico Cancer Center. By the time he was in his mid-60s, Rod had been charting annual PSA readings; however, he now wishes he’d known about the significance of what such a collection of slightly increasing readings can mean. Upon his diagnosis, a relative urged him to go to our office, get to know people, and start becoming educated. He did. Rod worked at Sandia National Labs for about 35 years in the public relations area.
Charles Rowland

Charles Rowland

Treasurer

Charles had a robotic radical prostatectomy in February of 2011. In the months following, it became evident that a metastasis had occurred prior to the surgery. He is now in the active surveillance protocol, and is grateful that his PSA levels have remained so low that no further treatment has been necessary.
Charles began consulting with PCSANM in January of 2011 and joined as a member very soon after his surgery. He had been practicing architecture during this time, and has since retired to devote more of his time to the organization and its efforts to help men and their families understand all of the options available to them upon diagnosis.

Jan Marfyak

Jan Marfyak

Secretary

Louis Reimer (Lou) has served on the Prostate Cancer Support Association Board of Directors for the past eight years and was elected as Chairman in July, 2012, serving in that capacity until the election of the current Chairman, Steve Denning, in July, 2016. In addition, Lou has been, and continues to perform the duties of Programs Chairman

Lou was diagnosed with prostate cancer in 2002 at age 63 while living in Southern California. His “Numbers” at diagnosis were: PSA =10.5, Gleason 8 and several nodules on the left side of the prostate.

The local USToo support group was instrumental in changing his approach from surgery to ADT and helped him get an appointment with an Oncologist specializing in treating prostate cancer. The Oncologist ordered a Prostascint scan that showed prostate cancer in the prostate, the surrounding tissue, the seminal vesicles, and abdomen. The Oncologist prescribed 19 months of aggressive ADT – a combination of Lupron, Casodex, and Proscar. This combination was very effective in forcing the PSA to a nadir of 0.004 during treatment. Afterwards the PSA rebounded to 0.03 and then declined to <0.01, where it has remained for many years.

He is grateful for the education and support from the knowledgeable USToo members in Southern California. When Lou moved to New Mexico he joined the local USToo chapter, the Prostate Cancer Support Association of New Mexico. He is trying to educate and support newly (and not so newly diagnosed) patients as a way to repay the debit he owes to the support personnel that got him on a good track.

arles had a robotic radical prostatectomy in February of 2011. In the months following, it became evident that a metastasis had occurred prior to the surgery. He is now in the active surveillance protocol, and is grateful that his PSA levels have remained so low that no further treatment has been necessary.
Charles began consulting with PCSANM in January of 2011 and joined as a member very soon after his surgery. He had been practicing architecture during this time, and has since retired to devote more of his time to the organization and its efforts to help men and their families understand all of the options available to them upon diagnosis.

Lou Reimer

Lou Reimer

Board Member

Louis Reimer (Lou) has served on the Prostate Cancer Support Association Board of Directors for the past eight years and was elected as Chairman in July, 2012, serving in that capacity until the election of the current Chairman, Steve Denning, in July, 2016. In addition, Lou has been, and continues to perform the duties of Programs Chairman

Lou was diagnosed with prostate cancer in 2002 at age 63 while living in Southern California. His “Numbers” at diagnosis were: PSA =10.5, Gleason 8 and several nodules on the left side of the prostate.

The local USToo support group was instrumental in changing his approach from surgery to ADT and helped him get an appointment with an Oncologist specializing in treating prostate cancer. The Oncologist ordered a Prostascint scan that showed prostate cancer in the prostate, the surrounding tissue, the seminal vesicles, and abdomen. The Oncologist prescribed 19 months of aggressive ADT – a combination of Lupron, Casodex, and Proscar. This combination was very effective in forcing the PSA to a nadir of 0.004 during treatment. Afterwards the PSA rebounded to 0.03 and then declined to <0.01, where it has remained for many years.

He is grateful for the education and support from the knowledgeable USToo members in Southern California. When Lou moved to New Mexico he joined the local USToo chapter, the Prostate Cancer Support Association of New Mexico. He is trying to educate and support newly (and not so newly diagnosed) patients as a way to repay the debit he owes to the support personnel that got him on a good track.

arles had a robotic radical prostatectomy in February of 2011. In the months following, it became evident that a metastasis had occurred prior to the surgery. He is now in the active surveillance protocol, and is grateful that his PSA levels have remained so low that no further treatment has been necessary.
Charles began consulting with PCSANM in January of 2011 and joined as a member very soon after his surgery. He had been practicing architecture during this time, and has since retired to devote more of his time to the organization and its efforts to help men and their families understand all of the options available to them upon diagnosis.

Dave Ball

Dave Ball

Board Member

David was first diagnosed with prostate cancer in December, 2007 and has been treated twice with radiation therapy. He is currently receiving intermittent hormone therapy. David’s goal is to make available to others diagnosed with prostate cancer the same outstanding assistance and information he received from the PCSA so they may have a great quality of life while managing their prostate cancer.
David retired in January, 2008 after 40 years working for the government and private industry as an Engineer and Project/Program Manager. David graduated from the University of New Mexico with a BS degree in Mechanical Engineering and an MS degree in Civil Engineering from New Mexico State University.
David enjoys spending much of his time with his wife Louella, three daughters, and four grandchildren. In his spare time David plays golf and enjoys providing his services to the PCSA.wing, it became evident that a metastasis had occurred prior to the surgery. He is now in the active surveillance protocol, and is grateful that his PSA levels have remained so low that no further treatment has been necessary.
Charles began consulting with PCSANM in January of 2011 and joined as a member very soon after his surgery. He had been practicing architecture during this time, and has since retired to devote more of his time to the organization and its efforts to help men and their families understand all of the options available to them upon diagnosis.

Jerry Cross

Jerry Cross

Board Member

Phil York

Phil York

Board Member

After 17 years of monitoring his PSA, Phil had a biopsy with prostate cancer cells. Finding resources and the “Buddy List” at Prostate Cancer Assoc. of NM, he chose external beam radiation in 2017. Phil is volunteering as a member on the board as a way to pay back the valuable information and support the association provided to him.

Phil is a semi-retired Communications Technician from Public Service Co. of New Mexico and now maintains Automated Weather Observations Systems at small New Mexico airports. 

 

Advisory Board:

Michael Davis, MD

Advisory Board Member

Robert Leibowitz, MD

Advisory Board Member

Thomas Schroeder, MD

Advisory Board Member

Satyan Shah, MD

Advisory Board Member